CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-28 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −5,000 | $20.00 | $100K | 92,138 |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Option exercise 10b5-1 | +37,792 | $1.23 | $46K | 252,024 |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −37,792 | $15.05 | $569K | 214,232 |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,792 | 130,874 | ||
| 2025-10-06 | Jarrett Jennifer Chief Operating Officer | Option exercise 10b5-1 | +12,500 | $1.23 | $15K | 226,732 |
| 2025-10-06 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −12,500 | $14.54 | $182K | 214,232 |
| 2025-10-06 | Jarrett Jennifer Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 168,666 | ||
| 2025-09-29 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,831 | $13.00 | $37K | 27,363 |
| 2025-09-05 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −1,579 | $11.88 | $19K | 30,194 |
| 2025-06-10 | PERLMAN ANDREW J Director | Grant or award | +13,300 | 42,625 | ||
| 2025-06-10 | PERLMAN ANDREW J Director | Grant or award · Stock Option (Right to Buy) | +38,300 | 38,300 | ||
| 2025-06-10 | FALBERG KATHRYN E Director | Grant or award | +13,300 | 68,600 | ||
| 2025-06-10 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Rights to Buy) | +38,300 | 38,300 | ||
| 2025-06-10 | Machado Patrick Director | Grant or award | +13,300 | 38,600 | ||
| 2025-06-10 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +38,300 | 38,300 | ||
| 2025-06-10 | Ribas Antoni Director | Grant or award | +13,300 | 43,650 | ||
| 2025-06-10 | Ribas Antoni Director | Grant or award · Stock Option (Right to Buy) | +38,300 | 38,300 | ||
| 2025-06-10 | Lacey David L. Director | Grant or award | +13,300 | 70,952 | ||
| 2025-06-10 | Lacey David L. Director | Grant or award · Stock Option (Right to Buy) | +38,300 | 38,300 | ||
| 2025-06-10 | KANEKO YASUNORI Director | Grant or award | +13,300 | 33,300 |
Page 5 of 9 · 177 trades